Will SYNTAX results mean more patients with complex lesions now receive DES? Join our international panel of experts, Drs Serruys, Mohr, Beatt, and Smith as they discuss optimal management of patients with complex cardiovascular lesions.
What's the latest on the use of drug-eluting stents in "complex" patients? Join our international panel of experts, Drs Feldman, Kappetein, Mack, and Morice as they discuss the challenges of treating patients with complex lesions - what evidence do we have now and what can we expect to see in the near future?
Join Dr Gregg Stone as he presents the most comprehensive DES/BMS meta-analysis ever! Expert faculty Drs Hermiller, Moses, Popma and Turco also debate current DES safety and efficacy data.
Acknowledgements
CME provider: Medscape.
The Complex Cardiovascular Lesions theme is supported by an independent educational grant from Boston Scientific.